An evaluation of the effects on the ovaries of hyperbaric oxygen therapy in a rat model of premature ovarian failure created with cyclophosphamide
- PMID: 36908093
- PMCID: PMC10013088
- DOI: 10.4274/tjod.galenos.2023.47817
An evaluation of the effects on the ovaries of hyperbaric oxygen therapy in a rat model of premature ovarian failure created with cyclophosphamide
Abstract
Objective: To evaluate hyperbaric oxygen therapy (HBO) based on ovarian histology, total antioxidant status (TAS), total oxidant status (TOS), and anti-müllerian hormone (AMH), in the ovarian insufiency (POI) model created with cyclophosphamide (CYP).
Materials and methods: The rats were separated into 3 groups of the control group (n=6), the CYP group (n=6), and the CYP+HBO group (n=6). The rats in the CYP group and the CYP+HBO group were injected intraperitoneally with 200 mg/kg CYP on day 1, followed by 8 mg/kg/day for 14 days to create POI. From the 15th day onwards, the rats in the CYP+HBO group were placed in a hyperbaric cabin and exposed to 100% oxygen at 2.4 atm pressure for one h, and were then returned to their cages at the end of the hour.
Results: A statistically significant decrease was determined in the primordial and primary follicle counts in the CYP group compared with the control group (p<0.05). In the CYP+HBO group, a statistically significant increase was determined in the primordial and primary follicle counts (p<0.05). The serum AMH levels were seen to be significantly decreased in the CYP group compared with both the control group and the CYP+HBO groups. The HBO was seen to decrease TOS and increase TAS.
Conclusion: HBO could be an alternative treatment to minimize the effect of ovarian follicle loss caused by CYP, which is used for treating tumors that commonly occur in young females of reproductive age.
Keywords: Anti-müllerian hormone; cyclophosphamide; hyperbaric oxygen; ovarian failure.
©Copyright 2023 by Turkish Society of Obstetrics and Gynecology | Turkish Journal of Obstetrics and Gynecology published by Galenos Publishing House.
Conflict of interest statement
Conflict of Interest: No conflict of interest was declared by the authors.
Figures
Similar articles
-
Determination of the effects of bone marrow derived mesenchymal stem cells and ovarian stromal stem cells on follicular maturation in cyclophosphamide induced ovarian failure in rats.Taiwan J Obstet Gynecol. 2019 Jan;58(1):53-59. doi: 10.1016/j.tjog.2018.11.010. Taiwan J Obstet Gynecol. 2019. PMID: 30638481
-
Early postnatal methoxychlor exposure inhibits folliculogenesis and stimulates anti-Mullerian hormone production in the rat ovary.J Endocrinol. 2006 Dec;191(3):549-58. doi: 10.1677/joe.1.06592. J Endocrinol. 2006. PMID: 17170213
-
Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.Hum Reprod. 2018 May 1;33(5):844-859. doi: 10.1093/humrep/dey045. Hum Reprod. 2018. PMID: 29534229
-
AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice.FASEB J. 2019 Jan;33(1):1278-1287. doi: 10.1096/fj.201801089R. Epub 2018 Aug 16. FASEB J. 2019. PMID: 30113879
-
Hyperbaric oxygen treatment for experimental cyclophosphamide-induced hemorrhagic cystitis.J Urol. 1993 Jun;149(6):1617-21. doi: 10.1016/s0022-5347(17)36462-5. J Urol. 1993. PMID: 8501819
Cited by
-
An overview of different methods to establish a murine premature ovarian failure model.Animal Model Exp Med. 2024 Dec;7(6):835-852. doi: 10.1002/ame2.12477. Epub 2024 Sep 1. Animal Model Exp Med. 2024. PMID: 39219374 Free PMC article. Review.
References
-
- Findlay JK, Hutt KJ, Hickey M, Anderson RA. How Is the Number of Primordial Follicles in the Ovarian Reserve Established? Biol Reprod. 2015;93:111. - PubMed
-
- Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004;428:145–50. - PubMed
-
- Ahmad SS, Reinius MA, Hatcher HM, Ajithkumar TV. Anticancer chemotherapy in teenagers and young adults: managing long term side effects. BMJ. 2016;354:i4567. - PubMed
-
- De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet. 2010;376:911–21. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous